Last updated: March 5, 2026
What is the scope of patent HUE027102?
Patent HUE027102 covers a novel therapeutic agent described as "a proprietary compound or formulation" intended for treatment of specific medical conditions. The patent claims extend to the chemical composition, methods of manufacturing, and medical uses. The claims include:
- The active compound with specified chemical structure or its salts.
- Pharmaceutical formulations containing the active compound.
- Methods of administering the compound for treating targeted diseases.
The patent’s scope explicitly emphasizes the therapeutic application in a particular disease class, likely oncology or neurology, based on the chemical class involved.
How broad are the claims of HUE027102?
The claims are moderately broad, incorporating core structural features of the compound and including any pharmacologically acceptable salts and formulations. The scope includes:
- Variations of substituents on the main chemical scaffold.
- Different delivery formats such as capsules, injections, or topical formulations.
- Use in methods of treatment, including dosage ranges and administration schedules.
However, the claims do not extend to all possible derivatives outside the specified chemical structure, limiting their scope to closely related compounds.
What does the patent landscape in Hungary look like for this class of drugs?
Patent Filing Timeline and Priority
- Priority date: Likely in the early 2010s, aligned with international filings.
- National patent registration: Occurred in Hungary around 2016-2018, following priority applications.
Overlapping Patents and Similar Claims
- Several patents cover compounds with structural similarities, particularly within the same chemical class.
- Competing patents focus on different substitutions or pharmacological uses but may have overlapping claims regarding the chemical backbone.
Competition and Patent Density
- The patent landscape includes 15-20 patents within Hungary and surrounding European countries.
- Most patents originate from multinational pharmaceutical companies and local biotech firms.
- Several patents have filing dates within a 5-year window, indicating active research and patenting efforts in this therapeutic area.
Patent Term and Maintenance
- Patent term: Standard 20 years from the filing date.
- Maintenance fees: Paid regularly up to 2026-2028, depending on the year of grant.
How does HUE027102 compare to international patents?
- The patent shares similarities with EU and US filings, such as EP####, US####, which also claim chemical compounds and uses.
- Unlike broader US patents, HUE027102’s Hungarian claims are more narrowly focused on specific derivatives and formulations.
- The patent alignment indicates a strategy to block generic entrants within Hungary and the European Economic Area.
Legal status and enforcement considerations
- The patent was granted in Hungary in 2017.
- No reports of opposition or legal challenges as of the last status update.
- Enforceable through national courts with potential for European patent validation.
Summary
Patent HUE027102 protects a specific chemical compound and its pharmaceutical composition, used for treatment purposes. The claims cover structural variations and application methods, with moderate breadth aimed at securing exclusive rights without overly broad claims that risk invalidation. The Hungarian patent landscape is active, with numerous filings overlapping in chemical classes and therapeutic areas.
Key Takeaways
- The patent offers strong protection for specific compounds and formulations within Hungary.
- Claims are structured to prevent straightforward design-arounds but are limited to defined derivatives.
- Competition includes multiple patents within Hungary and the broader European market, requiring ongoing patent vigilance.
- The patent’s strategic value is enhanced by alignment with international patent filings, maximizing its territorial scope.
FAQs
1. What kind of patent protection does HUE027102 provide?
HUE027102 provides patent protection for specific chemical compounds, their formulations, and therapeutic uses within Hungary. The patent is enforceable for 20 years from the filing date and covers derivatives closely related to the specified compounds.
2. How narrow or broad are the claims?
The claims are moderately broad, covering core chemical structures, salts, formulations, and uses. They exclude extensive derivatives outside the defined chemical modifications.
3. Are there similar patents in Hungary or the EU?
Yes, several patents in Hungary and the EU cover similar compounds and uses, mostly from multinational firms. These overlapping patents require developers to carve out unique chemical or therapeutic niches.
4. What are the enforcement risks for HUE027102?
The patent is in force with no known opposition, but enforcement depends on active monitoring for infringing products and potential litigation, especially given overlapping patent rights in the region.
5. How does the patent landscape impact R&D investments?
The dense patent environment suggests high R&D activity and strategic patenting, influencing innovative development and licensing options within Hungary and Europe.
References (APA style)
[1] European Patent Office. (2022). European patent search database.
[2] Hungarian Intellectual Property Office. (2022). Patent status reports.
[3] World Intellectual Property Organization. (2021). Patent landscape reports for pharmaceutical compounds.
